Dichlorphenamide
Pronunciation
(dye klor FEN a mide)
U.S. Brand Names
Daranide®
Synonyms
Diclofenamide
Generic Available
No
Canadian Brand Names
Daranide®
Use
Adjunct in treatment of open-angle glaucoma and perioperative treatment for angle-closure glaucoma
Pregnancy Risk Factor
C
Contraindications
Hypersensitivity to dichlorphenamide or any component of the formulation; severe pulmonary obstruction; severe renal impairment
Warnings/Precautions
Chemical similarities are present among sulfonamides, sulfonylureas, carbonic anhydrase inhibitors, thiazides, and loop diuretics (except ethacrynic acid). In patients with allergy to one of these compounds, a risk of cross-reaction exists; avoid use when previous reaction has been severe.
Adverse Reactions
>10%:
Central nervous system: Fatigue, malaise
Gastrointestinal: Diarrhea, anorexia, metallic taste
Genitourinary: Polyuria
1% to 10%:
Central nervous system: Mental depression, drowsiness
Renal: Renal calculi
Drug Interactions
Increased lithium excretion and altered excretion of other drugs by alkalinization of the urine
Dosage
Adults: Oral: 100-200 mg to start followed by 100 mg every 12 hours until desired response is obtained; maintenance dose: 25-50 mg 1-3 times/day
Patient Education
Report numbness or tingling of extremities to physician; ability to perform tasks requiring mental alertness and/or physical coordination may be impaired; take with food if GI upset occurs; notify if flank pain or rash occurs
Nursing Implications
Monitor electrolytes
Dental Health: Effects on Dental Treatment
Key adverse event(s) related to dental treatment: Metallic taste.
Dental Health: Vasoconstrictor/Local Anesthetic Precautions
No information available to require special precautions
Mental Health: Effects on Mental Status
Sedation is common; may cause depression
Mental Health: Effects on Psychiatric Treatment
May rarely cause bone marrow suppression; use caution with clozapine and carbamazepine; may increase the excretion of lithium but should not be used to treat lithium toxicity
Dosage Forms
Tablet: 50 mg
International Brand Names
Antidrasi® (IT); Daranide® (CA); Diclofenamid® (DE); Fenamide® (IT); Glauconide® (ES); Glaumid® (IT); Oratrol® (BE, CZ, HK, LU)
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's
accreditation program
is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s
editorial process
. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
|
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.